Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Free Cash Flow (2020 - 2026)

Journey Medical filings provide 6 years of Free Cash Flow readings, the most recent being -$6.3 million for Q4 2025.

  • On a quarterly basis, Free Cash Flow fell 382.43% to -$6.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$12.4 million, a 36.31% decrease, with the full-year FY2025 number at -$12.4 million, up 48.44% from a year prior.
  • Free Cash Flow hit -$6.3 million in Q4 2025 for Journey Medical, down from -$2.4 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $18.7 million in Q3 2023 to a low of -$19.1 million in Q1 2022.
  • Median Free Cash Flow over the past 5 years was -$3.3 million (2021), compared with a mean of -$2.9 million.
  • Biggest five-year swings in Free Cash Flow: crashed 1504.56% in 2022 and later surged 357.44% in 2023.
  • Journey Medical's Free Cash Flow stood at -$3.2 million in 2021, then dropped by 19.65% to -$3.8 million in 2022, then plummeted by 330.66% to -$16.5 million in 2023, then surged by 113.47% to $2.2 million in 2024, then crashed by 382.43% to -$6.3 million in 2025.
  • The last three reported values for Free Cash Flow were -$6.3 million (Q4 2025), -$2.4 million (Q3 2025), and -$942000.0 (Q2 2025) per Business Quant data.